Related Articles
Expression of osteopontin and CDX2: Indications of phenotypes and prognosis in advanced gastric cancer
Osteopontin as a biomarker for osteosarcoma therapy and prognosis (Review)
Identification of brefelamide as a novel inhibitor of osteopontin that suppresses invasion of A549 lung cancer cells
Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines
The O‑glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivo